As of March 26, we're $27,100 in the red for the quarter. Donate here to support this vital work
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

The New Cholesterol Guidelines And Conflicts Of Interest
Key Excerpts from Article on Website of Forbes


Forbes, November 20, 2013
Posted: September 29th, 2019
https://www.forbes.com/sites/edsilverman/2013/11/20/the-new-...

The American Heart Association and the American College of Cardiology released new guidelines for prescribing cholesterol-lowering medicines. The big winners are expected to be the drug makers that sell statins, since other types of pills were not recommended. Of the 15 panelists that authored these new guidelines, six reported having recent or current ties to drugmakers that already sell or are developing cholesterol medications. And among the half dozen who disclosed these relationships was one of the two panel co-chairs, which contradicts an Institute of Medicine suggestion about managing conflicts and leadership roles on such panels. To be specific, the Institute of Medicine wrote that, whenever possible, guideline development group members should not have conflicts of interest ... and the chair or co-chairs should not be a person(s) with conflicts of interest. The Institute of Medicine also wrote that members with conflicts should not represent a majority (here is the IOM report). One of the reasons the IOM recently recommended eliminating rather than managing financial conflicts of interest in guideline development groups is because of concerns about implicit bias, says Lisa Cosgrove ... at the University of Massachusetts. When individuals have commercial ties they are vulnerable to developing subtle, but sometimes powerful, pro-industry ways of thinking. Transparency ... can actually worsen the problem, because some people think simply disclosing a tie relieves any moral concern.

Note: For lots more on this, see an informative article titled "The Statin Mafia Censors Pharmaceutical Harm." For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.


Latest News


Key News Articles from Years Past